Skip to main content
Professional Technical IVT

Vascular Occlusion

A serious adverse event in filler procedures in which injected material compresses or enters a blood vessel, potentially causing tissue ischaemia, necrosis, or blindness.

Full Definition

Vascular occlusion (VO) is one of the most severe complications of injectable filler treatment, occurring when filler is inadvertently injected into or around a vessel, obstructing blood flow. Depending on the vessel involved, sequelae can include skin necrosis, scarring, or—in the case of ophthalmic artery occlusion—permanent vision loss. Recognising early signs (blanching, pain, mottling) is critical to prompt management. Editors reviewing adverse event reports must ensure the term is not softened to 'vascular compromise' when a true occlusion is documented, as the distinction carries medicolegal weight.

Usage

Usage note: Do not substitute 'vascular compromise' for 'vascular occlusion' in formal incident documentation; the terms have different clinical and medicolegal implications.

In Context

  • "The adverse event report must clearly document whether the vascular occlusion resulted in permanent tissue loss." — Adverse event report
  • "All practitioners must be trained in the management of vascular occlusion prior to performing filler treatments." — Training standards document

Also known as

VO filler-induced vascular occlusion intravascular injection

Don't confuse with

bruising haematoma Tyndall effect

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON